Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Lopez

Showing results (291-300 of 369) with videos related to

Pageof 37
Sort By:
The Journal of Biological Chemistry|September 10, 2010
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasisMian M K Shahzad, Jesusa M Arevalo, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector deliveryHaifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Oncotarget|April 21, 2017
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerNoa Rabinowicz, Lingegowda S Mangala, Kevin R Brown, et al.
Cancer Research|November 3, 2007
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancerCharles N Landen, Yvonne G Lin, Guillermo N Armaiz Pena, et al.
Circulation|April 9, 2019
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart AssociationSusan C Gilchrist, Ana Barac, Philip A Ades, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
Oncotarget|March 5, 2015
Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growthGuillermo N Armaiz-Pena, Vianey Gonzalez-Villasana, Archana S Nagaraja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Pageof 37

Showing results (291-300 of 369) with videos related to

Sort By:
Pageof 37
The Journal of Biological Chemistry|September 10, 2010
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasisMian M K Shahzad, Jesusa M Arevalo, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector deliveryHaifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Oncotarget|April 21, 2017
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerNoa Rabinowicz, Lingegowda S Mangala, Kevin R Brown, et al.
Cancer Research|November 3, 2007
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancerCharles N Landen, Yvonne G Lin, Guillermo N Armaiz Pena, et al.
Circulation|April 9, 2019
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart AssociationSusan C Gilchrist, Ana Barac, Philip A Ades, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
Oncotarget|March 5, 2015
Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growthGuillermo N Armaiz-Pena, Vianey Gonzalez-Villasana, Archana S Nagaraja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Pageof 37